top of page
In The News
January 6, 2026
CU Boulder pre-seed investment fuels cancer ‘moonshot’ spinout Illumen Therapeutics
In an ongoing effort to bridge a pervasive investment gap in innovation funding, the University of Colorado Boulder has awarded pre-seed funding to Illumen Therapeutics, developing cancer treatments based on discoveries from startup co-founder Roy Parker’s lab at CU Boulder.
bottom of page